These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8056992)

  • 1. A multicentre comparative trial of moclobemide, imipramine and placebo in major depressive disorder. UK Moclobemide Study Group.
    Int Clin Psychopharmacol; 1994; 9(2):109-13. PubMed ID: 8056992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moclobemide, imipramine and placebo in the treatment of major depression.
    Versiani M; Nardi AE; Mundim FD; Alves A; Schmid-Burgk W
    Acta Psychiatr Scand Suppl; 1990; 360():57-8. PubMed ID: 2248073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group.
    Versiani M; Amrein R; Stabl M
    Int Clin Psychopharmacol; 1997 Jul; 12(4):183-93. PubMed ID: 9347378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of moclobemide, imipramine and placebo in depressive patients.
    Ucha Udabe R; Márquez CA; Traballi CA; Portes N
    Acta Psychiatr Scand Suppl; 1990; 360():54-6. PubMed ID: 2123367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparative trial of moclobemide v. imipramine and placebo in major depressive episodes.
    Versiani M; Oggero U; Alterwain P; Capponi R; Dajas F; Heinze-Martin G; Marquez CA; Poleo MA; Rivero-Almanzor LE; Rossel L
    Br J Psychiatry Suppl; 1989 Oct; (6):72-7. PubMed ID: 2695129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
    Kok LP; Tsoi WF
    Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of moclobemide on depressive symptoms and cognitive performance in a geriatric population: a controlled comparative study versus imipramine.
    Pancheri P; Delle Chiaie R; Donnini M; Seripa S; Gambino C; Vicario E; Trillo L
    Clin Neuropharmacol; 1994; 17 Suppl 1():S58-73. PubMed ID: 7954485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moclobemide versus imipramine in depressed out-patients: a double-blind multi-centre study.
    Rimón R; Jääskeläinen J; Kaartinen P; Kalli A; Kilponen E; Koskinen T; Nikkilä H; Pirttiperä V; Seppälä J
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):141-7. PubMed ID: 8468435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a reversible monoamine oxidase-A inhibitor versus imipramine in subgroups of depressed patients.
    Bizière K; Berger M
    Acta Psychiatr Scand Suppl; 1990; 360():59-60. PubMed ID: 2248074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter double-blind study of moclobemide and maprotiline.
    Vaz-Serra A; Figueira ML; Firmino H; Albuquerque AJ; Jara JM; Pestana LC
    Clin Neuropharmacol; 1994; 17 Suppl 1():S38-49. PubMed ID: 7954483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of moclobemide compared with imipramine in the treatment of major depressive disorder. Double-blind multicenter study, Austria.
    Hebenstreit GF; Loidl M; Baumhackl U; Gallhofer B; Geretsegger C; Radmayr E; Saletu M; Schöny W; Stabl M
    J Neural Transm Suppl; 1990; 32():177-84. PubMed ID: 2089087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
    Duarte A; Mikkelsen H; Delini-Stula A
    J Psychiatr Res; 1996; 30(6):453-8. PubMed ID: 9023788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moclobemide, imipramine, and placebo in the treatment of major depression (DSM III).
    Versiani M; Nardi AE; Mundim FD; Alves AB
    J Neural Transm Suppl; 1989; 28():65-75. PubMed ID: 2794994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study.
    Baumhackl U; Bizière K; Fischbach R; Geretsegger C; Hebenstreit G; Radmayr E; Stabl M
    Br J Psychiatry Suppl; 1989 Oct; (6):78-83. PubMed ID: 2695130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
    Lecrubier Y; Guelfi JD
    Acta Psychiatr Scand Suppl; 1990; 360():18-23. PubMed ID: 2248063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moclobemide (Ro 11-1163) versus imipramine in the treatment of depression.
    Casacchia M; Moll E
    Acta Psychiatr Scand Suppl; 1990; 360():43. PubMed ID: 2248067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
    Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
    Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of efficacy of moclobemide or imipramine in the treatment of recurrent brief depression: results from an exploratory randomized, double-blind, placebo-controlled treatment study.
    Baldwin DS; Green M; Montgomery SA
    Int Clin Psychopharmacol; 2014 Nov; 29(6):339-43. PubMed ID: 24859491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
    Versiani M; Nardi AE; Figueira IL; Stabl M
    Acta Psychiatr Scand Suppl; 1990; 360():24-8. PubMed ID: 2123366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial.
    Roth M; Mountjoy CQ; Amrein R
    Br J Psychiatry; 1996 Feb; 168(2):149-57. PubMed ID: 8837903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.